88398-97-4

Basic information

• Product Name: 1H-Pyrazole-3-sulfonamide,1-methyl-(9CI)
• Synonyms: 1H-Pyrazole-3-sulfonamide,1-methyl-(9CI);1-Methyl-1H-Pyrazole-3-sulfonaMide
• CAS NO: 88398-97-4
• Molecular Formula: C4H7N3O2S
• Molecular Weight: 161.18228
• Product Categories: SULFONAMIDE
• Mol File: 88398-97-4.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1H-Pyrazole-3-sulfonamide,1-methyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrazole-3-sulfonamide,1-methyl-(9CI)(88398-97-4)
• EPA Substance Registry System: 1H-Pyrazole-3-sulfonamide,1-methyl-(9CI)(88398-97-4)

Safety Data

• Hazardous Substances Data: 88398-97-4(Hazardous Substances Data)

Usage

General Description

1H-Pyrazole-3-sulfonamide,1-methyl-(9CI) is a chemical compound with the molecular formula C4H6N4O2S. It is a derivative of pyrazole and contains a sulfonamide group. 1H-Pyrazole-3-sulfonamide,1-methyl-(9CI) is primarily used in the field of medicinal chemistry and pharmaceutical research, where it is being investigated for its potential biological activities and therapeutic applications. Its structure and properties make it a promising candidate for the development of new drugs, particularly in the treatment of various diseases and conditions. Further research and studies are ongoing to fully understand its pharmacological and physiological effects.

Upstream product

• 89501-90-6 1-methyl-1H-pyrazole-3-benzenesulfonyl chloride 
• 1904-31-0 methyl-1 amino-3 pyrazole 

Relevant articles and documents

2-AMINO-N-(AMINO-OXO-ARYL-LAMBDA6-SULFANYLIDENE)ACETAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE

The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 2-amino-N-(amino-oxo-aryl-λ6- sulfanylidene)acetamide compounds (referred to herein as ANASIA compounds) that, inter alia, inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetase (aaRS) (e.g., bacterial leucyl-tRNA synthetase, LeuRS). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit (e.g., selectively inhibit) bacterial aminoacyl-tRNA synthetase; to treat disorders that are ameliorated by the inhibition (e.g., selective inhibition) of bacterial aminoacyl-tRNA synthetase; to treat bacterial infections; etc.

SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME

ABSTRACT The present invention provides for certain sulfonyl ureas and related compounds which have advantageous properties and show useful activity in the inhibition of activation of the NLRP3 inflammasome. Such compounds are useful in the treatment of a wide range of disorders in which the inflammation process, or more specifically the NLRP3 inflammasome, have been implicated as being a key factor.

Herbicidal diazoles sulfonamides

This invention relates to herbicidal heterocyclic aminocarbonyl diazole sulfonamides compounds, compositions thereof and a method for their use to control the growth of undesired vegetation.